Global Nuclear Medicine & Radiopharmaceuticals Market Research Report 2019

Table of Contents

Executive Summary

1 Nuclear Medicine & Radiopharmaceuticals Market Overview

• 1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals
• 1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
  • 1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Diagnostic Radioisotopes
  • 1.2.3 Therapeutic Radioisotopes
• 1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application
  • 1.3.1 Nuclear Medicine & Radiopharmaceuticals Consumption Comparison by Application (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Cardiology
  • 1.3.4 Other
• 1.3 Global Nuclear Medicine & Radiopharmaceuticals Market by Region
  • 1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size
  • 1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue (2014-2025)
  • 1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Production (2014-2025)

2 Global Nuclear Medicine & Radiopharmaceuticals Market Competition by Manufacturers

• 2.1 Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Nuclear Medicine & Radiopharmaceuticals Production Sites, Area Served, Product Types
• 2.5 Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation and Trends
  • 2.5.1 Nuclear Medicine & Radiopharmaceuticals Market Concentration Rate
  • 2.5.2 Nuclear Medicine & Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Regions

• 3.1 Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Regions
• 3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions (2014-2019)
• 3.3 Global Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Nuclear Medicine & Radiopharmaceuticals Production
  • 3.4.1 North America Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
  • 3.4.2 North America Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Nuclear Medicine & Radiopharmaceuticals Production
  • 3.5.1 Europe Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
  • 3.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Nuclear Medicine & Radiopharmaceuticals Production (2014-2019)
  • 3.6.1 China Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
  • 3.6.2 China Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Nuclear Medicine & Radiopharmaceuticals Production (2014-2019)
  • 3.7.1 Japan Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
  • 3.7.2 Japan Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Nuclear Medicine & Radiopharmaceuticals Consumption by Regions

• 4.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption by Regions
• 4.2 North America Nuclear Medicine & Radiopharmaceuticals Consumption (2014-2019)
• 4.3 Europe Nuclear Medicine & Radiopharmaceuticals Consumption (2014-2019)
• 4.4 China Nuclear Medicine & Radiopharmaceuticals Consumption (2014-2019)
• 4.5 Japan Nuclear Medicine & Radiopharmaceuticals Consumption (2014-2019)

5 Global Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price Trend by Type

• 5.1 Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Type (2014-2019)
• 5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2014-2019)
• 5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2014-2019)
• 5.4 Global Nuclear Medicine & Radiopharmaceuticals Production Growth by Type (2014-2019)

6 Global Nuclear Medicine & Radiopharmaceuticals Market Analysis by Applications

• 6.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
• 6.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Nuclear Medicine & Radiopharmaceuticals Business

• 7.1 Bracco Imaging
  • 7.1.1 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.1.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Bayer
  • 7.2.1 Bayer Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.2.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Mallinckrodt
  • 7.3.1 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.3.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Nordion
  • 7.4.1 Nordion Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.4.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Triad Isotopes
  • 7.5.1 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.5.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Lantheus
  • 7.6.1 Lantheus Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.6.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 IBA Group
  • 7.7.1 IBA Group Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.7.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.7.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 GE Healthcare
  • 7.8.1 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.8.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 China Isotope & Radiation
  • 7.9.1 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.9.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Jubilant Pharma
  • 7.10.1 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
  • 7.10.2 Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
  • 7.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Eli Lilly
• 7.12 Advanced Accelerator Applications
• 7.13 SIEMENS
• 7.14 Dongcheng
• 7.15 Navidea

8 Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Analysis

• 8.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
• 8.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Nuclear Medicine & Radiopharmaceuticals Distributors List
• 9.3 Nuclear Medicine & Radiopharmaceuticals Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Nuclear Medicine & Radiopharmaceuticals Market Forecast

• 11.1 Global Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast
  • 11.1.1 Global Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Nuclear Medicine & Radiopharmaceuticals Price and Trend Forecast (2019-2025)
• 11.2 Global Nuclear Medicine & Radiopharmaceuticals Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Nuclear Medicine & Radiopharmaceuticals Production, Revenue Forecast (2019-2025)
• 11.3 Global Nuclear Medicine & Radiopharmaceuticals Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2019-2025)
  • 11.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2019-2025)
  • 11.3.3 China Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2019-2025)
  • 11.3.4 Japan Nuclear Medicine & Radiopharmaceuticals Consumption Forecast (2019-2025)
• 11.4 Global Nuclear Medicine & Radiopharmaceuticals Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Nuclear Medicine & Radiopharmaceuticals Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List